Tarsus Pharmaceuticals, Inc (TARS) insider trading
Every open-market stock purchase and sale by Tarsus Pharmaceuticals, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Elizabeth Yeu Lin (C-suite exec) and 3 others sold $5.1M in the last 90 days.
- Last insider buy: Andrew D. Goldberg (Director), $19K, 2 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $19.8M (25 sales). Last close $78.09 on Sep 18, 2026.
Recent TARS insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 15, 2026 | William J Link Phd (Director) | Sold | $915K |
| Sep 15, 2026 | William J Link Phd (Director) | Sold | $60K |
| Sep 15, 2026 | William J Link Phd (Director) | Sold | $5.3K |
| Sep 15, 2026 | Wendy L Yarno (Director) | Bought (not open market) | — |
| Sep 15, 2026 | William J Link Phd (Director) | Bought (not open market) | — |
| Sep 15, 2026 | David E I Pyott (Director) | Bought (not open market) | — |
| Sep 4, 2026 | Bobak R. Azamian (CEO) | Sold | $641K |
| Sep 4, 2026 | Elizabeth Yeu Lin (C-suite exec) | Sold | $485K |
| Sep 4, 2026 | Elizabeth Yeu Lin (C-suite exec) | Sold | $458K |
| Sep 4, 2026 | Seshadri Neervannan (COO) | Sold | $388K |
| Sep 4, 2026 | Bobak R. Azamian (CEO) | Sold | $265K |
| Sep 4, 2026 | Elizabeth Yeu Lin (C-suite exec) | Sold | $143K |
| Sep 2, 2026 | Bobak R. Azamian (CEO) | Sold | $801K |
| Sep 2, 2026 | Elizabeth Yeu Lin (C-suite exec) | Sold | $431K |
| Sep 2, 2026 | Elizabeth Yeu Lin (C-suite exec) | Sold | $127K |
| Sep 1, 2026 | Elizabeth Yeu Lin (C-suite exec) | Sold | $340K |
| Jun 25, 2026 | David E I Pyott (Director) | Bought (not open market) | — |
| Jun 25, 2026 | Bhaskar Chaudhuri (Director) | Bought (not open market) | — |
| Jun 25, 2026 | William J Link Phd (Director) | Bought (not open market) | — |
| Jun 25, 2026 | Andrew D. Goldberg (Director) | Bought (not open market) | — |
| Jun 25, 2026 | Andrew D. Goldberg (Director) | Bought (not open market) | — |
| Jun 25, 2026 | Katherine Goodrich (Director) | Bought (not open market) | — |
| Jun 25, 2026 | Wendy L Yarno (Director) | Bought (not open market) | — |
| Jun 25, 2026 | Wendy L Yarno (Director) | Bought (not open market) | — |
| Jun 25, 2026 | Wendy L Yarno (Director) | Bought (not open market) | — |
Who's trading TARS
- William J Link Phd, Director: sold $4.5M (13 sales), last Sep 15, 2026
- Wendy L Yarno, Director: other filings, last Sep 15, 2026
- David E I Pyott, Director: other filings, last Sep 15, 2026
- Bobak R. Azamian, CEO: sold $5.2M (10 sales), last Sep 4, 2026
- Elizabeth Yeu Lin, C-suite exec: sold $2.2M (10 sales), last Sep 4, 2026
- Seshadri Neervannan, COO: sold $2M (6 sales), last Sep 4, 2026
- Bhaskar Chaudhuri, Director: other filings, last Jun 25, 2026
- Katherine Goodrich, Director: sold $183K (1 sale), last Jun 25, 2026
- Scott W Morrison, Director: other filings, last Jun 25, 2026
- Andrew D. Goldberg, Director: other filings, last Jun 25, 2026
- Jeffrey S Farrow, Officer: sold $1.3M (4 sales), last Jun 16, 2026
- Bryan Wahl, General Counsel: sold $850K (3 sales), last Mar 19, 2026
- Aziz Mottiwala, C-suite exec: sold $893K (3 sales), last Mar 19, 2026
- Dianne C. Whitfield, Officer: sold $2.7M (8 sales), last Mar 19, 2026
Get free alerts when an insider at Tarsus Pharmaceuticals, Inc files a new trade →